1.Medial Femoral Cutaneous Nerve(MFCN) and Posterior Femoral Cutaneous Nerve(PFCN) Conduction Study in Korean.
Jun Myoung PARK ; Ki Eon JANG ; Hui Sook LEE ; Hye Kyeong KIM ; Kwang Ik JEONG ; Dong Sik PARK
Journal of the Korean Academy of Rehabilitation Medicine 1998;22(1):142-147
Medial femoral cutaneous nerve(MFCN), a sensory branch of the femoral nerve, supplies the skin over the anteromedial aspect of the thigh and knee. Posterior femoral cutaneous nerve(PFCN), comprised of fibers originating from the anterior and posterior divisions of the first three sacral segments, supplies the skin over the posterior aspect of the thigh. Forty nerves of twenty healthy adults, ages from 20 to 58, were tested. The onset and peak latencies of MFCN were 2.3+/-0.2 ms and 2.9+/-0.2 ms respectively. The baseline to peak amplitude was 6.5+/-2.3 V. The onset and peak latencies of PFCN were 2.4+/-0.2 ms and 2.9+/-0.2 ms respectively. The baseline to peak amplitude was 7.1+/-1.7 V.
Adult
;
Equipment and Supplies
;
Femoral Nerve
;
Humans
;
Knee
;
Skin
;
Thigh
2.Phantom bladder pain.
Kyeong Eon PARK ; Kwang Seong CHEON ; Seong Ho OK ; Young Ju JEONG ; Heon Keun LEE
Korean Journal of Anesthesiology 2012;63(4):376-377
No abstract available.
Urinary Bladder
3.A Case of Trisomy 9 Mosaicism Confirmed by Microarray Test
Chang-Eon PARK ; Mi-Lm CHUNG ; Ji-Hye HWANG ; Min-Kyeong LEE
Kosin Medical Journal 2020;35(2):143-150
Trisomy 9 mosaicism syndrome is a rare chromosomal abnormality with a high incidence of natural abortion and perinatal death. This syndrome is characterized by intrauterine growth retardation, mental retardation, craniofacial dysmorphism including a prominent nasal bridge with a short root and a fish-shaped mouth with thin lips, skeletal abnormalities, congenital heart defects, and genital abnormalities. The incidence and severity of malformations depend on the percentage of trisomic cells in the different tissues. We report a neonate who had the characteristic features of trisomy 9 syndrome with dysmorphic features including micrognathia, microcephaly, a low-set and malformed ear, a prominent lip, and cardiac defect. No chromosomal abnormalities were detected on a routine peripheral blood chromosomal analysis; however, a chromosomal abnormality with trisomy 9 mosaicism (low-level mosaic type) was detected on genetic tests. This is thought to be due to the low proportion of trisomic cells, and for this reason, the patient in this case shows a better prognosis than four patients previously reported in Korea, they were all diagnosed by peripheral blood chromosome testing.
4.A Case of Trisomy 9 Mosaicism Confirmed by Microarray Test
Chang-Eon PARK ; Mi-Lm CHUNG ; Ji-Hye HWANG ; Min-Kyeong LEE
Kosin Medical Journal 2020;35(2):143-150
Trisomy 9 mosaicism syndrome is a rare chromosomal abnormality with a high incidence of natural abortion and perinatal death. This syndrome is characterized by intrauterine growth retardation, mental retardation, craniofacial dysmorphism including a prominent nasal bridge with a short root and a fish-shaped mouth with thin lips, skeletal abnormalities, congenital heart defects, and genital abnormalities. The incidence and severity of malformations depend on the percentage of trisomic cells in the different tissues. We report a neonate who had the characteristic features of trisomy 9 syndrome with dysmorphic features including micrognathia, microcephaly, a low-set and malformed ear, a prominent lip, and cardiac defect. No chromosomal abnormalities were detected on a routine peripheral blood chromosomal analysis; however, a chromosomal abnormality with trisomy 9 mosaicism (low-level mosaic type) was detected on genetic tests. This is thought to be due to the low proportion of trisomic cells, and for this reason, the patient in this case shows a better prognosis than four patients previously reported in Korea, they were all diagnosed by peripheral blood chromosome testing.
5.Role of Cardiac Transcription Factor Nkx2.5 on Cardiomyoplasty Model in vitro.
Eun Kyung SHIN ; Jeong Hyun PARK ; Dae Joong KIM ; Jang Hee HAHN ; Kyeong Han PARK ; Hoon Ki SUNG ; Joo Young KIM ; In Hwan SONG ; Eon Gi SUNG ; Yung Chang LEE
Korean Journal of Anatomy 2004;37(1):31-41
Despite therapeutic advance, the prevalence of ischemic heart disease continues to increase. Recently, cell transplantation of stem cell has been proposed as a strategy for cardiac repair following myocardial damage. However, low differentiation efficiency into cardiomyocyte and poor cell viability associated with transplantation have limited the reparative capacity of these cell. In this study, we engineered P19 embryonal carcinoma cells using plasmid vector to overexpress the transcription factor MEF2c, Nkx2.5 involved in cardiomyogenesis. We investigated 1) formation of intercellular junction of P19 in mono-culture and co-culture with cardiomyocyte for functional and structural synchronous contraction after transplantation, 2) differentiation into cardiomyocyte, 3) resistance to hypoxic condition. An P19 embryonal carcinoma cell line expressing GFP, MEF2c, Nkx2.5 was generated by gene transfection and clonal selection. Nkx2.5 overexpression induced connexin43 expression level decrease. Electron microscopy revealed myofibril organization and immunostaining with cTnT showed positive staining in P19-Nkx2.5, consistent with early stage cardiomyocyte. Connexin43 and N-cadherin was expressed between P19-MEF2c and cardiomyocyte, P19- Nkx2.5 and cardiomyocyte in co-culture. And beating rate of cardiomyocyte co-cultured with P19-Nkx2.5 increased much more than other group, even if P19-Nkx2.5 did not have synchronous contraction with cardiomyocyte. Additionally, P19-Nkx2.5 had a resistance against hypoxia. These result suggest that overexpression of Nkx2.5 induced differentiation of P19 into cardiomyocyte and would be electro-mechanical coupling with cardiomyocyte after transplantation. Futhermore, Nkx2.5 overexpression had protection potential to hypoxic injury. Therefore, P19 cell overexpressed Nkx2.5 would be promising cell source for further study of new therapy of myocardial disease and building up in vitro model.
Anoxia
;
Cadherins
;
Cardiomyopathies
;
Cardiomyoplasty*
;
Cell Survival
;
Cell Transplantation
;
Coculture Techniques
;
Connexin 43
;
Embryonal Carcinoma Stem Cells
;
Intercellular Junctions
;
Microscopy, Electron
;
Myocardial Ischemia
;
Myocytes, Cardiac
;
Myofibrils
;
Plasmids
;
Prevalence
;
Stem Cells
;
Transcription Factors*
;
Transfection
;
Transplants
6.Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model.
Il Woo SHIN ; In Seok JANG ; Seung Min LEE ; Kyeong Eon PARK ; Seong Ho OK ; Ju Tae SOHN ; Heon Keun LEE ; Young Kyun CHUNG
Korean Journal of Anesthesiology 2011;61(6):499-505
BACKGROUND: Ulinastatin has anti-inflammatory properties and protects organs from ischemia/reperfusion-induced injury. The aim of this study was to investigate whether ulinastatin provides a protective effect on a regional myocardial ischemia/reperfusion injury in an in vivo rat heart model and to determine whether the anti-inflammatory response is related to its myocardial protective effect. METHODS: Rats were randomized to two groups. One group is received ulinastatin (50,000 U/kg or 100,000 U/kg) diluted in normal saline and the other group is received normal saline, which was administered intraperitoneally 30 min before the ischemic insult. Reperfusion after 30 min of ischemia of the left coronary artery territory was applied. Hemodynamic measurements were recorded serially during 6 h after reperfusion. After the 6 h reperfusion, myocardial infarct size, cardiac enzymes, myeloperoxidase activity, and inflammatory cytokine levels were compared between the ulinastatin treated and untreated groups. RESULTS: Ulinastatin improved cardiac function and reduced infarct size after regional ischemia/reperfusion injury. Ulinastatin significantly attenuated tumor necrosis factor-alpha expression and reduced myeloperoxidase activity. CONCLUSIONS: Ulinastatin showed a myocardial protective effect after regional ischemia/reperfusion injury in an in vivo rat heart model. This protective effect of ulinastatin might be related in part to ulinastatin's ability to inhibit myeloperoxidase activity and decrease expression of tumor necrosis factor-alpha.
Animals
;
Coronary Vessels
;
Glycoproteins
;
Heart
;
Hemodynamics
;
Inflammation
;
Ischemia
;
Myocardial Reperfusion
;
Myocardium
;
Peroxidase
;
Rats
;
Reperfusion
;
Tumor Necrosis Factor-alpha
7.A Patient with Kikuchi's Disease: What Should Pain Clinicians Do?.
Kyeong Eon PARK ; Sebin KANG ; Seong Ho OK ; Il Woo SHIN ; Ju Tae SOHN ; Young Kyun CHUNG ; Heon Keun LEE
The Korean Journal of Pain 2012;25(3):188-190
Kikuchi's disease (KD) is an idiopathic and self-limiting necrotizing lymphadenitis that predominantly occurs in young females. It is common in Asia, and the cervical lymph nodes are commonly involved. Generally, KD has symptoms and signs of lymph node tenderness, fever, and leukocytopenia, but there are no reports on treatment for the associated myofacial pain. We herein report a young female patient who visited a pain clinic and received a trigger point injection 2 weeks before the diagnosis of KD. When young female patients with myofascial pain visit a pain clinic, doctors should be concerned about the possibility of KD, which is rare but can cause severe complications.
Asia
;
Facial Pain
;
Female
;
Fever
;
Histiocytic Necrotizing Lymphadenitis
;
Humans
;
Leukopenia
;
Lymph Nodes
;
Lymphadenitis
;
Myofascial Pain Syndromes
;
Neck Pain
;
Pain Clinics
;
Trigger Points
8.The Effect of the Spinal Block Level on the Requirements of Propofol for Sedation.
Il Woo SHIN ; Ji Eun GO ; Kyeong Eon PARK ; Ju Tae SOHN ; Young Kyun CHUNG ; Heon Keun LEE
Korean Journal of Anesthesiology 2006;50(6):642-645
BACKGROUND: It has been reported that spinal anesthesia has a sedative effect and so this decreases the hypnotic requirement of intravenous anesthetic. Therefore, we have conducted a prospective randomized study to investigate the effect of the spinal anesthesia level on the hypnotic requirements for conscious sedation. METHODS: Forty adult patients were scheduled to undergo spinal anesthesia, and they were randomly allocated to one of the two groups. After subarachnoid injection of 0.5% hyperbaric bupivacaine 16 mg, the patients in group 1 and group 2 were maintained in a reversed Trendelenburg position and a Trendelenburg position, respectively. After fifteen minutes, the target controlled infusion of propofol was started for achieving a target concentration of 1 microgram/ml, and the mean BIS for 1 min was checked after an effect site concentration (Ce) of 1 microgram/ml was reached. The target controlled infusion of propofol was restarted at a target concentration (Tc) of 1.5 microgram/ml, and the mean BIS for 1 min was checked after the Ce level of 1.5 microgram/ml was reached. RESULTS: The mean BIS at 1 microgram/ml Ce was 90.0 +/- 8.5 and 77.8 +/- 10.3 in group 1 and group 2, respectively. The mean BIS at 1.5 g/ml Ce was 73.6 +/- 19.4 and 60.0 +/- 13.1, respectively. CONCLUSIONS: There was a significant difference in the requirements of propofol for conscious sedation between the below T12 block group and the above T4 block group.
Adult
;
Anesthesia, Spinal
;
Bupivacaine
;
Conscious Sedation
;
Head-Down Tilt
;
Humans
;
Hypnosis
;
Hypnotics and Sedatives
;
Propofol*
;
Prospective Studies
9.Implantable Intrathecal Drug Delivery Pump in Complex Regional Pain Syndrome Patient : A case report.
Kyung Soo SEO ; Kyung Ream HAN ; Sae Young KIM ; Kyeong Eon PARK ; Chan KIM
The Korean Journal of Pain 2009;22(1):74-77
Implantable intrathecal pump is one of the therapeutic options for intractable pain. A 24-year-old male with complex regional pain syndrome was suffering from right lower extremity pain. He had all modalities of treatment including spinal cord stimulator. However, his pain had been worse in the past 6 months. His visual analogue pain scale (VAS) was 8-10 and he could not sit or walk. Only opioid was thought to be effective. Then, intrathecal pump was considered. We estimated the minimal effective dose of spinal morphine before implantation. 0.3 mg of morphine was injected intrathecally as a starting dose. Dosage had been increased up to 0.8 mg in 10 days. His VAS score decreased from 8 to 5. He could sleep without pain and walk with crutch. Therefore, intrathecal pump was inserted. He could tolerate to pain. This case suggests that intrathecal morphine delivery can provide effective treatment for intractable non-malignant pain.
Humans
;
Lower Extremity
;
Male
;
Morphine
;
Pain Measurement
;
Pain, Intractable
;
Spinal Cord
;
Stress, Psychological
;
Young Adult
10.The Effectiveness of a Three Phase Bone Scan for Making the Diagnosis of Complex Regional Pain Syndrome.
Nan Seol KIM ; Kyeong Eon PARK ; Sae Young KIM ; Yun Jeong CHAE ; Chan KIM ; Kyung Ream HAN
The Korean Journal of Pain 2009;22(1):33-38
BACKGROUND: Complex regional pain syndrome (CRPS) is still difficult to diagnose in the field of chronic pain management. CRPS is diagnosed by purely clinical criteria based on the characteristic signs and symptoms, which have to be differentiated from similar pain conditions like posttraumatic neuropathic pain. Until now, there has been a lack of objective diagnostic tools to confirm the diagnosis of CRPS. The aim of this study was to evaluate the usefulness of a three phase bone scan (TBS) for making the diagnosis of CRPS. METHODS: A total of 121 patients who had been diagnosed with CRPS were evaluated. All the patients were examined by performing a TBS as a part of the diagnostic work-up. A diffuse increased tracer uptake on the delayed image (phase III) was defined as a positive finding for CRPS. RESULTS: Forty-one patients (33.9%) out of 121 showed the positive results on the TBS. The patients with a duration of pain of less than 24 months had a significantly higher positive result (43.4%) on the TBS than did the patients with duration of pain longer than 24 months (12.1%). CONCLUSIONS: A TBS could give a better objective result for diagnosing CRPS for patients with a shorter duration of pain and a TBS gives little information for the diagnosis of CRPS in patients with a duration of pain longer than 24 months.
Chronic Pain
;
Humans
;
Neuralgia